PMC3147134_01
case report: patient with a large HCC Contrast enhanced CT evidencing a large infiltrative tumor of the left liver (a) with a portal vein thrombosis (b).
IJMI2011-398051.002.jpg
PMC3147134_01_IJMI2011-398051.002.jpg
fig2
Case report: delineation of the tumoral and injected lover VOI on SPECT/CT whole; injected liver VOI with SPECT/CT color scale (a), whole injected liver VOI with CT scale and visualisation of SPECT isocontour (b), tumoral VOI with SPECT/CT color scale (c) and tumoral VOI with CT scale and visualisation of SPECT isocontour (d).
IJMI2011-398051.003.jpg
PMC3147134_01_IJMI2011-398051.003.jpg
fig3
For each VOI, the threshold value was adjusted so that the isocontours of the distribution volume of MAA were superimposed on the fusion images that corresponded to the contours of the liver and tumor (Figure 3).
Case report: angiographic and scintigraphic data; right selective angiography (a), selective angiography of the common hepatic artery vascularizing segment IV and the left liver (b), SPECT (c) and SPECT/CT (d) after injection of the MAA at the level of the central hepatic artery revealing an unexpected uptake in the right liver, in addition to the expected uptake of segment IV and left liver (whole liver distribution, volume 1829cc).
IJMI2011-398051.004.jpg
PMC3147134_01_IJMI2011-398051.004.jpg
fig4
Case report: follow-up CT scan 4 months after injection of 5 GBq of in the central branch: major response.
IJMI2011-398051.005.jpg
PMC3147134_01_IJMI2011-398051.005.jpg
fig5
No toxicity was observed, and a major response was achieved (Figure 5).